Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 2003; Volume 306,Issue 1

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Ontogenesis of β-Adrenoceptor Signaling: Implications for Perinatal Physiology and for Fetal Effects of Tocolytic Drugs
    Theodore A. Slotkin, J. Todd Auman and Frederic J. Seidler
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 1-7; DOI: https://doi.org/10.1124/jpet.102.048421

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Contribution of Organic Anion Transporter 3 (Slc22a8) to the Elimination of p-Aminohippuric Acid and Benzylpenicillin across the Blood-Brain Barrier
    Ryota Kikuchi, Hiroyuki Kusuhara, Daisuke Sugiyama and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 51-58; DOI: https://doi.org/10.1124/jpet.103.049197
  • You have access
    Transfer of l-α-Acetylmethadol (LAAM) and l-α-Acetyl-N-normethadol (norLAAM) by the Perfused Human Placental Lobule
    Tatiana N. Nanovskaya, Sujal V. Deshmukh, Rachel Miles, Steve Burmaster and Mahmoud S. Ahmed
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 205-212; DOI: https://doi.org/10.1124/jpet.103.050690
  • You have access
    The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
    Bryan A. Ward, J. Christopher Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 287-300; DOI: https://doi.org/10.1124/jpet.103.049601
  • You have access
    The Site-Specific Transport and Metabolism of Tacrolimus in Rat Small Intestine
    Shigeki Tamura, Yuji Tokunaga, Rinta Ibuki, Gordon L. Amidon, Hitoshi Sezaki and Shinji Yamashita
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 310-316; DOI: https://doi.org/10.1124/jpet.103.050716
  • You have access
    Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin after Intravenous and Subcutaneous Dose Administration in Cynomolgus Monkeys
    Rohini Ramakrishnan, Wing K. Cheung, Francis Farrell, Linda Joffee and William J. Jusko
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 324-331; DOI: https://doi.org/10.1124/jpet.102.047191
  • You have access
    Effect of Atorvastatin on Apolipoprotein B100 Containing Lipoprotein Metabolism in Type-2 Diabetes
    Khadija Ouguerram, Thierry Magot, Yassine Zäir, J. S. Marchini, Bernard Charbonnel, Herve Laouenan and Michel Krempf
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 332-337; DOI: https://doi.org/10.1124/jpet.103.048991

BEHAVIORAL PHARMACOLOGY

  • You have access
    The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in Rats
    M. Solinas, L. V. Panlilio, K. Antoniou, L. A. Pappas and S. R. Goldberg
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 93-102; DOI: https://doi.org/10.1124/jpet.102.047928
  • You have access
    Metabotropic Glutamate Subtype 5 Receptors Modulate Locomotor Activity and Sensorimotor Gating in Rodents
    Gene G. Kinney, Maryann Burno, Una C. Campbell, Lisa M. Hernandez, Dana Rodriguez, Linda J. Bristow and P. Jeffrey Conn
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 116-123; DOI: https://doi.org/10.1124/jpet.103.048702
  • You have access
    Risperidone Attenuates the Discriminative-Stimulus Effects of d-Amphetamine in Humans
    Craig R. Rush, William W. Stoops, Lon R. Hays, Paul E. A. Glaser and Lon S. Hays
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 195-204; DOI: https://doi.org/10.1124/jpet.102.048439
  • You have access
    5-Hydroxytryptamine (5-HT)2 Receptor Involvement in Acute 5-HT-Evoked Scratching but Not in Allergic Pruritus Induced by Dinitrofluorobenzene in Rats
    Hiroshi Nojima and E. Carstens
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 245-252; DOI: https://doi.org/10.1124/jpet.103.049239
  • You have access
    The Subtype-Selective Nicotinic Acetylcholine Receptor Agonist SIB-1553A Improves Both Attention and Memory Components of a Spatial Working Memory Task in Chronic Low Dose 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Monkeys
    J. S. Schneider, J. P. Tinker, F. Menzaghi and G. K. Lloyd
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 401-406; DOI: https://doi.org/10.1124/jpet.103.051912

CARDIOVASCULAR

  • You have access
    Enhancement of Angiogenesis by Endogenous Substance P Release and Neurokinin-1 Receptors During Neurogenic Inflammation
    Hélène C. Seegers, Vivienne C. Hood, Bruce L. Kidd, Simon C. Cruwys and David A. Walsh
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 8-12; DOI: https://doi.org/10.1124/jpet.103.050013
  • You have access
    Nitric Oxide Inhibitor Nω-Nitro-l-arginine Methyl Ester Potentiates Induction of Heme Oxygenase-1 in Kidney Ischemia/Reperfusion Model: A Novel Mechanism for Regulation of the Oxygenase
    Robert D. Mayer, Xiaojun Wang and Mahin D. Maines
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 43-50; DOI: https://doi.org/10.1124/jpet.102.048686
  • You have access
    BM-573, a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, Prevents Pig Myocardial Infarction Induced by Coronary Thrombosis
    S. Rolin, M. Petein, V. Tchana-Sato, J. M. Dogne, P. Benoit, B. Lambermont, A. Ghuysen, P. Kolh and B. Masereel
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 59-65; DOI: https://doi.org/10.1124/jpet.102.046607
  • You have access
    Protective Effect of Chronic Vitamin C Treatment on Endothelial Function of Apolipoprotein E-Deficient Mouse Carotid Artery
    Takuya Matsumoto, Livius V. d'uscio, Daihiko Eguchi, Masahiko Akiyama, Leslie A. Smith and Zvonimir S. Katusic
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 103-108; DOI: https://doi.org/10.1124/jpet.103.049163
  • You have access
    Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
    D. L. Lee, B. R. Wamhoff, L. C. Katwa, H. K. Reddy, D. J. Voelker, J. L. Dixon and M. Sturek
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 132-140; DOI: https://doi.org/10.1124/jpet.103.049577
  • You have access
    Differential Effects of Phosphodiesterase-Sensitive and -Resistant Analogs of cAMP on Initiation of Contraction in Cardiac Ventricular Myocytes
    Gregory R. Ferrier and Susan E. Howlett
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 166-178; DOI: https://doi.org/10.1124/jpet.103.049676
  • You have access
    Ectonucleotidase in Sympathetic Nerve Endings Modulates ATP and Norepinephrine Exocytosis in Myocardial Ischemia
    Casilde Sesti, Motohiro Koyama, M. Johan Broekman, Aaron J. Marcus and Roberto Levi
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 238-244; DOI: https://doi.org/10.1124/jpet.103.049874
  • You have access
    Effects of Chronic Ethanol Feeding on Clonidine-Evoked Reductions in Blood Pressure, Heart Rate, and Their Variability: Time-Domain Analyses
    Mahmoud M. El-Mas and Abdel A. Abdel-Rahman
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 271-278; DOI: https://doi.org/10.1124/jpet.102.048355

CELLULAR AND MOLECULAR

  • You have access
    Evidence That Nuclear Factor-κB Activation Is Critical in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Integrity and That Its Inactivation Is Essential in Epidermal Growth Factor-Mediated Protection of the Monolayers of Intestinal Epithelia
    A. Banan, A. Farhadi, J. Z. Fields, E. Mutlu, L. Zhang and A. Keshavarzian
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 13-28; DOI: https://doi.org/10.1124/jpet.102.047415
  • You have access
    Green Tea Polyphenols Induce Differentiation and Proliferation in Epidermal Keratinocytes
    Stephen Hsu, Wendy B. Bollag, Jill Lewis, Qin Huang, Baldev Singh, Mohamed Sharawy, Tetsuya Yamamoto and George Schuster
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 29-34; DOI: https://doi.org/10.1124/jpet.103.049734
  • You have access
    Amide Local Anesthetics Potently Inhibit the Human Tandem Pore Domain Background K+ Channel TASK-2 (KCNK5)
    Christoph H. Kindler, Matthias Paul, Hilary Zou, Canhui Liu, Bruce D. Winegar, Andrew T. Gray and C. Spencer Yost
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 84-92; DOI: https://doi.org/10.1124/jpet.103.049809
  • You have access
    The Use of Bioluminescence Resonance Energy Transfer 2 to Study Neuropeptide Y Receptor Agonist-Induced β-Arrestin 2 Interaction
    Magnus M. Berglund, Douglas A. Schober, Michael A. Statnick, Patricia H. McDonald and Donald R. Gehlert
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 147-156; DOI: https://doi.org/10.1124/jpet.103.051227

ENDOCRINE AND REPRODUCTIVE

  • You have access
    Pharmacology of (2S,4Z)-N-[(2S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2′-methyl[1,1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a New Potent and Selective Nonpeptide Antagonist of the Oxytocin Receptor
    Rocco Cirillo, Enrico Gillio Tos, Matthias K. Schwarz, Anna Quattropani, Alexander Scheer, Marc Missotten, Jerôme Dorbais, Anthony Nichols, Francesco Borrelli, Claudio Giachetti, Lucia Golzio, Paolo Marinelli, Russell J. Thomas, Claude Chevillard, Florence Laurent, Karine Portet, Claude Barberis and André Chollet
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 253-261; DOI: https://doi.org/10.1124/jpet.103.049395

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Toxicity of Acetaminophen, Salicylic Acid, and Caffeine for First-Passage Rat Renal Inner Medullary Collecting Duct Cells
    Qi Cai, Natalia I. Dmitrieva, Luis F. Michea, Gerson Rocha, Douglas Ferguson and Maurice B. Burg
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 35-42; DOI: https://doi.org/10.1124/jpet.102.047431
  • You have access
    Ursodeoxycholate Reduces Ethinylestradiol Glucuronidation in the Rat: Role in Prevention of Estrogen-Induced Cholestasis
    Enrique J. Sánchez Pozzi, Fernando A. Crocenzi, José M. Pellegrino, Viviana A. Catania, Marcelo G. Luquita, Marcelo G. Roma, Emilio A. Rodríguez Garay and Aldo D. Mottino
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 279-286; DOI: https://doi.org/10.1124/jpet.103.049940
  • You have access
    Glucagon-Like Peptide-2 and Common Therapeutics in a Murine Model of Ulcerative Colitis
    Marie-Claude L'Heureux and Patricia L. Brubaker
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 347-354; DOI: https://doi.org/10.1124/jpet.103.051771
  • You have access
    Uptake of Serotonin at the Apical and Basolateral Membranes of Human Intestinal Epithelial (Caco-2) Cells Occurs through the Neuronal Serotonin Transporter (SERT)
    Fátima Martel, Rosário Monteiro and Clara Lemos
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 355-362; DOI: https://doi.org/10.1124/jpet.103.049668

INFLAMMATION AND IMMUNOPHARMACOLOGY

  • You have access
    Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Interferon-β1a in Monkeys
    Donald E. Mager, Berend Neuteboom, Constantinos Efthymiopoulos, Alain Munafo and William J. Jusko
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 262-270; DOI: https://doi.org/10.1124/jpet.103.049502

NEUROPHARMACOLOGY

  • You have access
    Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist
    Kazushige Ohno, Rie Tsutsumi, Naoyuki Matsumoto, Hiroshi Yamashita, Yoko Amada, Jun-Ichi Shishikura, Hiroshi Inami Shin-Ichi Yatsugi, Masamichi Okada, Shuichi Sakamoto and Tokio Yamaguchi
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 66-72; DOI: https://doi.org/10.1124/jpet.103.049973
  • You have access
    Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics
    Jordi Riba, Marta Valle, Gloria Urbano, Mercedes Yritia, Adelaida Morte and Manel J. Barbanoj
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 73-83; DOI: https://doi.org/10.1124/jpet.103.049882
  • You have access
    Converging Protein Kinase Pathways Mediate Adenylyl Cyclase Superactivation upon Chronic δ-Opioid Agonist Treatment
    Eva V. Varga, Marc K. Rubenzik, Dagmar Stropova, Masano Sugiyama, Vanessa Grife, Victor J. Hruby, Kenner C. Rice, William R. Roeske and Henry I. Yamamura
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 109-115; DOI: https://doi.org/10.1124/jpet.103.049643
  • You have access
    Multidrug Resistance Protein MRP2 Contributes to Blood-Brain Barrier Function and Restricts Antiepileptic Drug Activity
    Heidrun Potschka, Maren Fedrowitz and Wolfgang Löscher
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 124-131; DOI: https://doi.org/10.1124/jpet.103.049858
  • You have access
    Nocistatin and Prepro-Nociceptin/Orphanin FQ 160–187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, Respectively
    Makoto Inoue, Toshiko Kawashima, Richard G. Allen and Hiroshi Ueda
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 141-146; DOI: https://doi.org/10.1124/jpet.103.049361
  • You have access
    Studies of μ-, κ-, and δ-Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys
    M. C. H. Ko, H. Lee, C. Harrison, M. J. Clark, H. F. Song, N. N. Naughton, J. H. Woods and J. R. Traynor
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 179-186; DOI: https://doi.org/10.1124/jpet.103.050625
  • You have access
    Effect of N-(4-Acetyl-1-piperazinyl)-p-fluorobenzamide Monohydrate (FK960), an Antidementia Drug with a Novel Mechanism of Action, on Regional Cerebral Blood Flow and Glucose Metabolism in Aged Rhesus Macaques Studied with Positron Emission Tomography
    Akihiro Noda, Hiroyuki Takamatsu, Nobuya Matsuoka, Satoshi Koyama, Hideo Tsukada and Shintaro Nishimura
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 213-217; DOI: https://doi.org/10.1124/jpet.103.050245
  • You have access
    Inhibitors of Cyclooxygenase-2, but Not Cyclooxygenase-1 Provide Structural and Functional Protection against Quinolinic Acid-Induced Neurodegeneration
    Heather C. Salzberg-Brenhouse, Er-Yun Chen, Dwaine F. Emerich, Sam Baldwin, Ken Hogeland, Sharon Ranelli, Denise Lafreniere, Brigido Perdomo, Leah Novak, Theodora Kladis, Karen Fu, Anthony S. Basile, Jeffrey H. Kordower and Raymond T. Bartus
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 218-228; DOI: https://doi.org/10.1124/jpet.103.049700
  • You have access
    Evaluation of the Ocular Hypotensive Response of Serotonin 5-HT1A and 5-HT2 Receptor Ligands in Conscious Ocular Hypertensive Cynomolgus Monkeys
    Jesse A. May, Marsha A. McLaughlin, Najam A. Sharif, Mark R. Hellberg and Thomas R. Dean
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 301-309; DOI: https://doi.org/10.1124/jpet.103.049528
  • You have access
    Distinct Recognition of Substrates by the Human and Drosophila Serotonin Transporters
    G. J. Rodríguez, D. L. Roman, K. J. White, D. E. Nichols and E. L. Barker
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 338-346; DOI: https://doi.org/10.1124/jpet.103.048751
  • You have access
    Synthesis and Characterization of NESS 0327: A Novel Putative Antagonist of the CB1 Cannabinoid Receptor
    Stefania Ruiu, Gèrard A. Pinna, Giorgio Marchese, Jean-Mario Mussinu, Pierluigi Saba, Simone Tambaro, Paola Casti, Romina Vargiu and Luca Pani
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 363-370; DOI: https://doi.org/10.1124/jpet.103.049924
  • You have access
    Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy
    Christophe Rousselle, Philippe Clair, Maria Smirnova, Yuri Kolesnikov, Gavril W. Pasternak, Stéphanie Gac-Breton, Anthony R. Rees, Jean-Michel Scherrmann and Jamal Temsamani
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 371-376; DOI: https://doi.org/10.1124/jpet.102.048520
  • You have access
    N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties
    Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu, Mohamed Hachicha, Lori Schmid, Laykea Tafesse, Qun Sun, Yakov Rotshteyn, Joseph Francis, James Limberis, Shiazah Malik, Edward R. Whittemore and Dianne Hodges
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 377-386; DOI: https://doi.org/10.1124/jpet.102.045674
  • You have access
    N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain
    James D. Pomonis, James E. Harrison, Lilly Mark, David R. Bristol, Kenneth J. Valenzano and Katharine Walker
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 387-393; DOI: https://doi.org/10.1124/jpet.102.046268
  • You have access
    Buprenorphine Blocks ϵ- and μ-Opioid Receptor-Mediated Antinociception in the Mouse
    Hirokazu Mizoguchi, Amanda Spaulding, Randy Leitermann, Hsiang-En Wu, Hiroshi Nagase and Leon F. Tseng
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 394-400; DOI: https://doi.org/10.1124/jpet.103.048835
  • You have access
    SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation
    C. Cohen, O. E. Bergis, F. Galli, A. W. Lochead, S. Jegham, B. Biton, J. Léonardon, P. Avenet, F. Sgard, F. Besnard, D. Graham, A. Coste, A. Oblin, O. Curet, C. Voltz, A. Gardes, D. Caille, G. Perrault, P. George, P. Soubrié and B. Scatton
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 407-420; DOI: https://doi.org/10.1124/jpet.103.049262

TOXICOLOGY

  • You have access
    Protein Kinase C Mediates Repair of Mitochondrial and Transport Functions after Toxicant-Induced Injury in Renal Cells
    Grażyna Nowak
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 157-165; DOI: https://doi.org/10.1124/jpet.103.050336
  • You have access
    In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats
    Teri Wadsworth, Hataya Poonyagariyagorn, Elinore Sullivan, Dennis Koop and Charles E. Roselli
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 187-194; DOI: https://doi.org/10.1124/jpet.102.048645
  • You have access
    Characterization of Sulfamethoxazole and Sulfamethoxazole Metabolite-Specific T-Cell Responses in Animals and Humans
    John Farrell, Dean J. Naisbitt, Nicola S. Drummond, Jan P. H. Depta, F. Javier Vilar, Munir Pirmohamed and B. Kevin Park
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 229-237; DOI: https://doi.org/10.1124/jpet.103.050112
  • You have access
    In Vitro Cytotoxicity of 4-Methylcatechol in Murine Tumor Cells: Induction of Apoptotic Cell Death by Extracellular Pro-Oxidant Action
    Kyoji Morita, Hideki Arimochi and Yoshinari Ohnishi
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 317-323; DOI: https://doi.org/10.1124/jpet.103.050351

Erratum

  • You have access
    Correction to “Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent Effect”
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 421;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 306 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 306, Issue 1
1 Jul 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • ENDOCRINE AND REPRODUCTIVE
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION AND IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Erratum
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics